semaglutide in weight management [55]
What This Means For Patients Better adherence = better outcomes Reduced cardiovascular disease risk More people actually taking their medication Fewer heart attacks and strokes prevented The most effective drug is the one patients actually take
Yang, C.-P., Chang, C.-M., Yang, C.-C., Pariante, C
A 2021 study included over 1300 participants, each given a weekly subcutaneous injection of 2.4 mg of semaglutide in addition to lifestyle modifications
Administered as a once-weekly subcutaneous injection, Wegovy has demonstrated significant efficacy in clinical trials for sustained weight loss when combined with lifestyle modifications
featured category Injectables Experience refined, natural-looking results with customizable injectables